Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2003-08-11
2010-06-15
Qazi, Sabiha (Department: 1612)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S571000, C560S062000, C560S059000, C562S466000, C562S472000
Reexamination Certificate
active
07737176
ABSTRACT:
The invention relates to compounds of the formula I:and to the pharmaceutically acceptable salts thereof, to processes for the preparation of them and to pharmaceutical compositions comprising them, which are useful especially for the treatment and prevention of dyslipidaemia, atherosclerosis and diabetes.
REFERENCES:
patent: 7465752 (2008-12-01), Zeiller et al.
patent: 7482484 (2009-01-01), Adje et al.
patent: 2051673 (1996-01-01), None
Randle et al. (Lancet, 1963, 785-789).
Lehmann, J.M. et al: An Antidiabetic Thiazolidinedione is a High Affinity Ligand for Peroxisome Proliferator-Activated Receptro (PPAR) The Journal of Biological Chemistry, vol. 270, No. 22, 1995, pp. 12953-12956, XP002228130.
Database WPI Section Ch, Week 199642 Derwent Publications Ltd., London, GB; AN 1996-423454 XP002228131.
Bonhomme Yves
Brunet Michel
Ferrand Gerard
Zeiller Jean-Jacques
Merck Patent GmbH
Millen White Zelano & Branigan P.C.
Qazi Sabiha
LandOfFree
Substituted arylhexadienoic acids and esters thereof which... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted arylhexadienoic acids and esters thereof which..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted arylhexadienoic acids and esters thereof which... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4186612